Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model

Shangxi Liu1, Mohit Kapoor, Christopher P Denton

  • 1University of Western Ontario, London, Ontario, Canada.

Arthritis and Rheumatism
|August 29, 2009
PubMed
Abstract

Insights

Fibroblast beta-1 integrin is crucial for skin fibrosis in scleroderma. Blocking this protein prevented fibrosis in a mouse model, suggesting a potential treatment target for systemic sclerosis.

Area of Science:

  • Dermatology
  • Fibrosis Research
  • Integrin Signaling

Background:

  • Activated adhesive signaling in fibroblasts is characteristic of scleroderma lesions.
  • Beta-1 integrin is a key mediator of fibroblast adhesive signaling.

Purpose of the Study:

  • To investigate the role of beta-1 integrin in skin fibrosis using a mouse model.
  • To determine if fibroblast-specific deletion of beta-1 integrin affects scleroderma development.

Main Methods:

  • Cutaneous sclerosis was induced using bleomycin injections in mice.
  • Fibroblast-specific beta-1 integrin deletion mice and control groups were compared.
  • Dermal thickness, collagen production, and alpha-smooth muscle actin-positive cells were quantified.

Main Results:

  • Bleomycin induced significant skin thickening and fibrosis in control mice.
  • Mice lacking fibroblast beta-1 integrin showed resistance to bleomycin-induced fibrosis.

Conclusions:

  • Fibroblast beta-1 integrin expression is essential for fibrogenesis.
  • Inhibiting beta-1 integrin could be a therapeutic strategy for cutaneous sclerosis.